Heart |
Postoperative myocardial ischemia in pancreatic surgery |
Remote ischemic preconditioning |
Postoperative myocardial injury and inflammatory response |
NCT03460938 (recruiting) |
Myocardial injury after percutaneous coronary intervention (PCI) |
Remote ischemic preconditioning |
Troponin |
NCT02581618 (completed) |
Myocardial injury after non-cardiac surgery |
Remote ischemic preconditioning |
Troponin |
NCT02427867 (recruiting) |
Perioperative myocardial ischemia in elective operation of abdominal aortic aneurysm |
Remote ischemic preconditioning |
CKMB and Troponin T |
NCT01523262 (unknown) |
Myocardial injury after PCI |
Remote ischemic preconditioning |
Myocardial injury and cardiac events |
NCT00970827 (completed) |
Myocardial damage in patients undergoing coronary artery bypass graft (CABG) surgery |
Epoetin-α |
Erk1/2, STAT5, Akt and caspase-3, CKMB, Troponin T, NT-proBNP |
NCT00524901 (completed) |
Minimally invasive mitral valve (MIMV) repair or replacement |
Volatile conditioning (sevoflurane) used during induction (preconditioning) |
|
NCT02551328 (recruiting) |
Adult patient undergoing open heart surgery |
Sevoflurane versus ischemic and Sevoflurane preconditioning |
Postoperative inotropic score |
NCT02715869 (completed) |
Chronic heart failure, NYHA class II–IV |
Neladenoson bialanate (BAY1067197, ADORA1 agonist) |
LVEF (%), NT-proBNP, Troponin T |
NCT02992288 (completed) |
Lung |
Lung injury during elective lung lobectomy |
Remote ischemic preconditioning |
Oxidative lung injury |
NCT02734654 (completed) |
Lung injury during CABG surgery |
Remote Ischemic preconditioning and postconditioning |
Pulmonary parameters and plasma IL-6, IL-8, IL-10, TNF-α levels |
NCT01144585 (completed) |
Lung transplantation |
Regadenoson (ADORA2A agonist) |
Activation of iNKT cells, pulmonary graft dysfunction, inflammatory cytokines |
NCT03072589 (recruiting) |
Liver |
Non-alcoholic steatohepatitis (NASH) |
CF102 (ADORA3 agonist) |
ALT, AST, HDL cholesterol |
NCT02927314 (recruiting) |
Kidney |
Contrast-induced acute kidney injury |
Remote ischemic preconditioning |
Creatinine, vascular and renal biomarkers |
NCT03236441 (recruiting) |
Stage III–IV chronic kidney disease undergoing planned coronary angiography |
Remote ischemic preconditioning |
Proinflammatory gene expression and anti-inflammatory gene expression in leukocytes, local release of adenosine and NO |
NCT02167152 (completed) |
Acute kidney injury in patients undergoing valvular heart surgery |
Human recombinant erythropoietin |
Incidence of acute kidney injury |
NCT01758861 (completed) |
Non-dialysis dependent chronic kidney disease |
Vadadustat (PHD inhibitor) |
Hemoglobin (Hb) |
NCT02648347 (recruiting) |
Chronic kidney disease patients initiating dialysis |
Daprodustat (PHD inhibitor) |
Hemoglobin (Hb) |
NCT03029208 (recruiting) |
Non-dialysis dependent chronic kidney disease |
Roxadustat (PHD inhibitor) |
Hemoglobin (Hb) |
NCT02021318 (active, not recruiting) |